Ligand Pharmaceuticals | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Amgen USD 11.97B 2.96B 2024-12
Arrowhead Research USD 51.79M 47.4M 2024-12
Baxter International USD 1.76B 344M 2024-12
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Eli Lilly USD 3.09B 175.1M 2025-03
Gilead Sciences USD 7.93B 2.06B 2025-03
GlaxoSmithKline GBP 4.46B 594M 2025-03
Glaxosmithkline GBP 3.87B 678M 2024-12
Insmed USD 555.03M 93.58M 2024-12
Ionis Pharmaceuticals USD 264.19M 22.12M 2025-03
Ligand Pharmaceuticals USD 72.31M 8.69M 2024-12
MacroGenics USD 182.84M 3.22M 2024-12
Merck USD 13.24B 1.35B 2024-12
Pacira USD 276.77M 30.81M 2024-12
Pfizer USD 1.04B 49M 2024-12
Veracyte USD 239.09M 34.99M 2024-12



Ligand Pharmaceuticals Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.